IVD in Singapore and Malaysia

    Published: January 1, 2014 | Price: $1,995 – $3,995

    IVD in Singapore and Malaysia Regional opportunities are the focus of IVD manufacturers that seek marginal growth. Southeast Asia represents a unique market for healthcare providers and their various business suppliers, including the in vitro diagnostics (IVD) industry. Kalorama details in this report two countries expected to provide business for IVD manufacturers: Singapore and Malaysia. IVD in Singapore and Malaysia contains the following information: Healthcare Statistics for Singapore and Malaysia Significant Hospitals in both countries The Clinical Lab Market in...
    The World Market for Immunoassays

    Published: November 6, 2013 | Price: $3,995 – $7,990

    The World Market for Immunoassays Visit our Immunoassays curated page for complete industry coverage. The immunoassay market is large and long-established, but at the same time highly competitive. Kalorama Information’s newly published report, The World Market for Immunoassays, describes the opportunities that exist for large IVD companies adopting new strategies and for new entrants to take market share. Immunoassays have been used in clinical laboratory medicine since the 1960s, and are indispensable tools in clinical diagnostics. A wide range of...
    The World Market for Infectious Disease Diagnostic Tests

    Published: October 21, 2013 | Price: $3,995 – $7,990

    Infectious diseases are among the most challenging issues facing health care delivery systems around the world today. The World Health Organisation estimates that more than 17 million people die of an infectious disease each year, with many of these acquired in hospitals. This Kalorama Information report, The World Market for Infectious Disease Diagnostic Tests, takes a comprehensive look at the markets for companies of testing products that can combat infectious disease threats. One of the Most Dynamic Areas of the...
    IVD in China

    Published: August 5, 2013 | Price: $2,500 – $5,000

    This report, IVD in China represents Kalorama's complete analysis on the Chinese IVD market.  The report provides an introduction to the healthcare system in China, the results of recent reform efforts, and issues and trends.  Regional breakouts of the Chinese system are provided.  The report describes the role that out-of-pocket expenditures and private concerns play in the delivery of healthcare in the nation.   The modern Chinese healthcare market was borne of and continues to be guided by the progressive...
    Cell Phone-Enabled Diagnostics: mHealth Applications in IVD

    Published: August 15, 2012 | Price: $995 – $1,995

    Mobile health has reached in vitro diagnostics and as this Kalorama report details, may change the industry forever.  Over the years, the introduction of transportable, portable, and handheld instruments has resulted in the migration of clinical lab testing from the central lab to a range of environments including self-testing, community clinics, the workplace, home, disaster care and most recently, retail convenience clinics. In spite of promotional materials that emphasize ease of use, the majority of currently available POC tests require...
    Kalorama 2010 Ultra Diagnostics Research Bundle

    Published: March 1, 2011 | Price: $300 – $600

    This bundle provides customers with three of the most intensely researched Kalorama Information reports covering the diagnostic industry authored by Shara Rosen, R.T., M.B.A. in 2010 and 2011 These reports will be provided in one PDF, each with its own table of contents. The bundle allows customers to save almost $4,500 off the cost of the individual reports. THE WORLDWIDE MARKET FOR IN VITRO DIAGNOSTIC TESTS, 7th Edition This 900 page report contains coverage of all segments of In Vitro...
    The Clinical Laboratory Services Market (Growth Opportunities, Competitive Analysis and Competitor Profiles)

    Published: February 1, 2010 | Price: $2,500 – $5,000

    The Clinical Laboratory Services Market (Growth Opportunities, Competitive Analysis and Competitor Profiles) Clinical laboratories are an essential part of the health industry. Kalorama Information estimates that approximately 80% of physicians' diagnoses are a result of laboratory tests.he constant pressure to reduce healthcare spending is shifting healthcare utilization in favor of the laboratory, making it an ever more valuable part of the treatment plan. As hospital stays are shortened, contact between the physician and patient is reduced, which places a larger role...
    Veterinary Diagnostics Markets

    Published: October 1, 2009 | Price: $995 – $1,990

    Diagnostic tests are an essential tool for confirming the health status of animals. The global impact of diseases such as bovine spongiform encephalopathy, foot and mouth disease, and highly pathogenic avian influenza has revealed that diagnostic tests play a key role not only in facilitating safe trade but also in many other areas such as the early detection of new diseases and the control of exotic or enzootic animal diseases. The market emerged from nascence in the early 2000s and...
    H1N1 (Swine Influenza) Market Assessment (Latest Data, Company Profiles, Implications for Immunoassays and Molecular Assays)

    Published: May 1, 2009 | Price: $250 – $1,600

    The outbreak of H1N1 (swine flu) highlighted the public health importance of improved testing techniques and providing market opportunities for manufacturers of diagnostic tests and other products related to the disease. These conclusions and others appear in a new report released from Kalorama Information: Swine Flu Market Alert by Kalorama's lead analyst, Shara Rosen. Regardless of the eventual severity of the epidemic, there will be distinct market impact on both immunoassay and molecular test makers, according to the report. The...
    In Vitro Diagnostics in a Recessionary Economy: IVD Market Forecasts, Analysis and Success Strategies

    Published: May 1, 2009 | Price: $250 – $3,395

    It is commonly asserted that in vitro diagnostics is a recession-proof industry. Kalorama Information's lead diagnostic analyst Shara Rosen tests that assumption and provides strategic conclusions in Shara Rosen's new report In Vitro Diagnostics in a Recessionary Economy. The economic problems that began slowing the U.S. economy keep spreading, with Europe and Japan following America into recession. The US is experiencing high unemployment rate and increased numbers of uninsured workers. But what impact is the downturn having on in vitro...
    Cell-Based Diagnostics – Technology, Applications, and Markets, 2nd Edition

    Published: November 1, 2007 | Price: $1,995 – $3,990

    No longer is cell-based diagnostics simply a histological study of biopsied and surgical tissues. Combinations of tests and technologies are coming together to create a new map of cell diagnostics. Image cytometry, microfluidics, microarrays, and biosensors, special immunohistochemical and in situ hybridization probes are creating new approaches to cell and tissue observation, diagnostics and pharmacogenomics. This report covers assay systems that use cells as the basic source material. Sources of the cells to be studied include peripheral blood, cord blood,...
    Diagnostic Equipment Service Conundrum – How Much Is Too Much?, How Little Is Too Little? , The

    Published: July 1, 2007 | Price: $995 – $3,990

    In light of laboratory pressures to do more with less, laboratory managers transfer cost control onto vendors by means of a constant push for price reductions. In this commercial climate, efficient management of customer and technical service extras is critical. Expertise in managing service offerings will help companies offer service programs that are just enough to differentiate them from the competition. Service programs that offer too much may result in revenue loss. Programs that are perceived to be inadequate place...
    Clinical Diagnostics in India – Market Sector Analyses and Participant Directory

    Published: December 1, 2006 | Price: $4,500 – $9,990

    The current population of India is 1.065 billion, and with a growth rate of 1.7%, India will surpass China to become the world’s largest country around 2030. For diagnostic manufacturers, this enormous market is just now being recognized as a high-growth area as the pace of economic growth in India accelerates and modern laboratory practices become established. This comprehensive report on the market for clinical in vitro diagnostic (IVD) tests in India covers both reagent and instrumentation markets for the...
    Cell-Based Diagnostics: Technology, Applications, and Markets

    Published: January 1, 2005 | Price: $3,500 – $7,000

    This report covers clinical and drug discovery assay systems that use cells as the basic source material. Sources of the cells to be studied include peripheral blood, cord blood, bone marrow, urine, cerebrospinal and other body fluids and tissue samples. Cell analysis is not a new laboratory procedure. Clinical diagnostics using cells and tissues is one of the oldest disciplines in laboratory medicine. Histological study of biopsy samples, the complete blood count, and the enumeration of disease-bearing cells have been...